Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Work In Process (2016 - 2024)

Historic Work In Process for Utah Medical Products (UTMD) over the last 14 years, with Q4 2024 value amounting to $1.4 million.

  • Utah Medical Products' Work In Process fell 592.15% to $1.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year decrease of 592.15%. This contributed to the annual value of $1.4 million for FY2024, which is 592.15% down from last year.
  • Utah Medical Products' Work In Process amounted to $1.4 million in Q4 2024, which was down 592.15% from $1.4 million recorded in Q3 2024.
  • In the past 5 years, Utah Medical Products' Work In Process ranged from a high of $1.7 million in Q3 2023 and a low of $1.1 million during Q2 2020
  • In the last 5 years, Utah Medical Products' Work In Process had a median value of $1.4 million in 2020 and averaged $1.4 million.
  • Data for Utah Medical Products' Work In Process shows a peak YoY increase of 3822.53% (in 2022) and a maximum YoY decrease of 1466.38% (in 2022) over the last 5 years.
  • Over the past 5 years, Utah Medical Products' Work In Process (Quarter) stood at $1.4 million in 2020, then grew by 1.67% to $1.4 million in 2021, then fell by 14.66% to $1.2 million in 2022, then grew by 25.98% to $1.5 million in 2023, then decreased by 5.92% to $1.4 million in 2024.
  • Its Work In Process was $1.4 million in Q4 2024, compared to $1.4 million in Q3 2024 and $1.4 million in Q2 2024.